These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18554804)

  • 1. Evaluation of the effects of biodegradable nanoparticles on a vaccine delivery system using AFM, SEM, and TEM.
    Kim BG; Kang IJ
    Ultramicroscopy; 2008 Sep; 108(10):1168-73. PubMed ID: 18554804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
    Borges O; Tavares J; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):278-90. PubMed ID: 17884394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
    Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O; Cordeiro-da-Silva A; Tavares J; Santarém N; de Sousa A; Borchard G; Junginger HE
    Eur J Pharm Biopharm; 2008 Jun; 69(2):405-16. PubMed ID: 18364251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
    Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
    Mangal S; Pawar D; Garg NK; Jain AK; Vyas SP; Rao DS; Jaganathan KS
    Vaccine; 2011 Jul; 29(31):4953-62. PubMed ID: 21575664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
    Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
    J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.
    Bharali DJ; Pradhan V; Elkin G; Qi W; Hutson A; Mousa SA; Thanavala Y
    Nanomedicine; 2008 Dec; 4(4):311-7. PubMed ID: 18640075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model.
    Shrestha B; Rath JP
    IET Nanobiotechnol; 2014 Dec; 8(4):201-7. PubMed ID: 25429498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monodisperse chitosan nanoparticles for mucosal drug delivery.
    Zhang H; Oh M; Allen C; Kumacheva E
    Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of multiple approaches towards an improved hepatitis B vaccine.
    Sanyal G; Shi L
    Expert Opin Ther Pat; 2009 Jan; 19(1):59-72. PubMed ID: 19441898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis.
    Yuan X; Yang X; Cai D; Mao D; Wu J; Zong L; Liu J
    Vaccine; 2008 Jul; 26(29-30):3727-34. PubMed ID: 18524427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, characterization and optimization of hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral delivery.
    Premaletha K; Licy CD; Jose S; Saraladevi A; Shirwaikar A; Shirwaikar A
    Pharm Dev Technol; 2012; 17(2):251-8. PubMed ID: 21108582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S; Saupe A; McBurney W; Rades T; Hook S
    J Pharm Pharmacol; 2008 Dec; 60(12):1591-600. PubMed ID: 19000363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
    Qian F; Cui F; Ding J; Tang C; Yin C
    Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.